Relevancia pronóstica de la proteína B cell lymphoma 2 (bcl-2) en los subtipos moleculares intrínsicos del carcinoma de mama

Fernández, Ángel; Mora, Eddy; Caleiras, Eduardo; Hernández, Daniela; Ojeda, Francis; Ojeda, Luisa; Castillo, Liliana; Salvidia, Felipe; Reigosa, Aldo.
Gac. méd. Caracas ; 126(2): 170-178, junio2018. ilus, Graf
Artigo em Espanhol | LIVECS, LILACS | ID: biblio-1007806

Documentos relacionados

  1. Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues.
  2. First Evidence for a Role of Siglec-8 in Breast Cancer.
  3. The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
  4. CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis.
  5. Invariant chain regulates endosomal fusion and maturation through an interaction with the SNARE Vti1b.
  6. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
  7. CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
  8. Structural insights into human MHC-II association with invariant chain.
  9. An essential MIF-CD74 signaling axis in kidney tubular regeneration, with prospects for precision medicine and pharmacological augmentation.
  10. Invariant chain p41 mediates production of soluble MHC class II molecules.